Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Review Article Volume 4 Issue 3

Juvenile Nasopharyngeal Angiofibroma: Key Points for Global Approach and Management

Mirian Cabral Moreira de Castro, Camila Braz Rodrigues da Silva, Tiago Fraga Vieira, Lilia Gama Pinho* and Mariana Moreira de Castro Denaro

Otolaryngology Department, Madre Teresa Hospital, and Santa Casa de Belo horizonte, Minas Gerais, Brazil

*Corresponding Author: Lilia Gama Pinho, Otolaryngology Department, Madre Teresa Hospital, and Santa Casa de Belo horizonte, Minas Gerais, Brazil.

Received: January 29, 2022; Published: February 25, 2022

Abstract

Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign, vascular neoplasm. Unilateral nasal obstruction, epistaxis, and lobulated mass extending into the nasopharynx are the most common symptoms. The diagnosis is based on clinical and imaging features and should be suspected in male adolescents presenting this triad. Treatment and surgical approaches are challenging, and lack of optimum management protocols still causes ongoing debate. In this review, I discuss the available surgical and clinical treatments for every tumor stage and focus on the techniques for optimal tumor resection. I also describe my surgical routine step by step and highlight tips and pitfalls based on thirty years of extensive study and practice which together may contribute to improved JNA management.

Keywords: Angiofibroma; Skull Base; Nasopharyngeal Neoplasms; Embolization; Therapeutic

References

  1. Garça MF., et al. “Juvenile Nasopharyngeal Angiofibroma”. Electronic Journal of General Medicine 4 (2010): 419-425.
  2. Makhasana JA., et al. “Juvenile nasopharyngeal angiofibroma”. Journal of Oral and Maxillofacial Pathology 2 (2016): 330.
  3. Zito J., et al. “Juvenile nasopharyngeal angiofibroma”. The Journal of the Louisiana State Medical Society 8 (2001): 395-398.
  4. Schlauder SM., et al. “Aromatase may play a critical role in the pathogenesis of juvenile nasopharyngeal angiofibroma”. Fetal and Pediatric Pathology 5 (2009): 232-238.
  5. Farag MM., et al. “Hormonal receptors in juvenile nasopharyngeal angiofibroma”. Laryngoscope 2 (1987): 208-211.
  6. Schick B., et al. “Die vaskuläre Komponente: Gedanken zur Entstehung des Angiofibroms [Aetiology of Angiofibromas: Reflection on their Specific Vascular Component]”. Laryngorhinootologie4 (2002): 280-284.
  7. Li W., et al. “Current perspectives on the origin theory of juvenile nasopharyngeal angiofibroma”. Discovery Medicine 150 (2019): 245-254.
  8. López F., et al. “Nasal juvenile angiofibroma: Current perspectives with emphasis on management”. Head Neck 5 (2017): 1033-1045.
  9. Bertazzoni G., et al. “Contemporary management of juvenile angiofibroma”. Current Opinion in Otolaryngology and Head and Neck Surgery 1 (2019): 47-53.
  10. Pryor SG., et al. “Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma”. Laryngoscope 7 (2005): 1201-1207.
  11. Garofalo P., et al. “Juvenile nasopharyngeal angiofibroma: comparison between endoscopic and open operative approaches”. Journal of Craniofacial Surgery 3 (2015): 918-821.
  12. Boghani Z., et al. “Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases”. Laryngoscope 4 (2013): 859-869.
  13. Alshaikh NA and Eleftheriadou A. “Juvenile nasopharyngeal angiofibroma staging: An overview”. Ear, Nose and Throat Journal 6 (2015): 12-22.
  14. Meher R., et al. “Massive juvenile nasopharyngeal angiofibroma: ode to the open surgical approach”. BMJ Case Reports (2017): bcr2016218731.
  15. Cloutier T., et al. “Juvenile nasopharyngeal angiofibroma: does the external approach still make sense?” Otolaryngology–Head and Neck Surgery 5 (2012): 958-963.
  16. Pei R., et al. “Efficacy and safety of preoperative internal maxillary arterial embolization with gelfoam for nasopharyngeal angiofibroma”. European Archives of Oto-Rhino-Laryngology 3 (2019): 865-869.
  17. Elhammady MS., et al. “Preoperative embolization of juvenile nasopharyngeal angiofibromas: transarterial versus direct tumoral puncture”. World Neurosurgery 3-4 (2011): 328-334.
  18. Lutz J., et al. “Preoperative Embolization to Improve the Surgical Management and Outcome of Juvenile Nasopharyngeal Angiofibroma (JNA) in a Single Center: 10-Year Experience”. Clinical Neuroradiology 4 (2016): 405-413.
  19. Santaolalla F., et al. “Efficacy of selective percutaneous embolization for the treatment of intractable posterior epistaxis and juvenile nasopharyngeal angiofibroma (JNA)”. Acta Oto-Laryngologica 12 (2009): 1456-1462.
  20. Overdevest JB., et al. “Patterns of vascularization and surgical morbidity in juvenile nasopharyngeal angiofibroma: A case series, systematic review, and meta-analysis”. Head Neck 2 (2018): 428-443.
  21. Ogawa AI., et al. “Juvenile angiofibroma: major and minor complications of preoperative embolization”. Rhinology2 (2012): 199-202.
  22. Szymańska A., et al. “Invasive growth patterns of juvenile nasopharyngeal angiofibroma: radiological imaging and clinical implications”. Acta Radiologica 6 (2014): 725-731.
  23. Wilson DA., et al. “Comparative analysis of surgical freedom and angle of attack of two minimal-access endoscopic transmaxillary approaches to the anterolateral skull base”. World Neurosurgery 3-4 (2014): e487-493.
  24. Gupta R and Agarwal SP. “Juvenile Nasopharyngeal Angiofibroma: Combined Approach for Excision, Transpalatal and Endoscopic; A New Perspective”. Indian Journal of Otolaryngology and Head and Neck Surgery 1 (2018): 125-129.
  25. Rupa V., et al. “Management and Outcome in Patients with Advanced Juvenile Nasopharyngeal Angiofibroma”. Journal of Neurological Surgery Part B. Skull Base 4 (2018): 353-360.
  26. Gołąbek W., et al. “Juvenile nasopharyngeal angiofibroma with intracranial extension - diagnosis and treatment”. Polish Journal of Otolaryngology 2 (2019): 1-7.
  27. Sun XC., et al. “Endoscopic assisted sublabial and buccolabial incision approach for juvenile nasopharyngeal angiofibroma with extensive infratemporal fossa extension”. International Journal of Pediatric Otorhinolaryngology 10 (2012): 1501-1506.
  28. Boghani Z., et al. “Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases”. Laryngoscope4 (2013): 859-869.
  29. Amdur RJ., et al. “Radiotherapy for juvenile nasopharyngeal angiofibroma”. Practical Radiation Oncology 4 (2011): 271-278.
  30. Mallick S., et al. “Long-term treatment outcomes of juvenile nasopharyngeal angiofibroma treated with radiotherapy”. ACTA Otorhinolaryngologica Italica 2 (2015): 75-79.
  31. Gates GA., et al. “Flutamide-induced regression of angiofibroma”. Laryngoscope6 (1992): 641-644.

Citation

Citation: Lilia Gama Pinho ., et al. “Juvenile Nasopharyngeal Angiofibroma: Key Points for Global Approach and Management.Acta Scientific Otolaryngology 4.3 (2022): 17-23.

Copyright

Copyright: © 2022 Lilia Gama Pinho ., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In







News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US